4-carboxyfluorescein has been researched along with verlukast in 1 studies
| Studies (4-carboxyfluorescein) | Trials (4-carboxyfluorescein) | Recent Studies (post-2010) (4-carboxyfluorescein) | Studies (verlukast) | Trials (verlukast) | Recent Studies (post-2010) (verlukast) |
|---|---|---|---|---|---|
| 116 | 0 | 53 | 396 | 14 | 115 |
| Protein | Taxonomy | 4-carboxyfluorescein (IC50) | verlukast (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 2.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filipeanu, CM; Klappe, K; Kok, JW; Koning, H; Müller, M; Veldman, RJ | 1 |
1 other study(ies) available for 4-carboxyfluorescein and verlukast
| Article | Year |
|---|---|
Differential expression of sphingolipids in MRP1 overexpressing HT29 cells.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Cell Survival; Ceramides; Colchicine; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fluoresceins; Galactosylceramides; Glucosylceramides; HT29 Cells; Humans; Immunoblotting; Immunohistochemistry; Microscopy, Confocal; Microtubules; Mitosis; Multidrug Resistance-Associated Proteins; Paclitaxel; Propionates; Quinolines; Signal Transduction; Sphingolipids; Vincristine | 2000 |